Sumitomo Pharma
(OTC) DNPUF
Sumitomo Pharma Financials at a Glance
Market Cap
$4.55B
Revenue (TTM)
$455.77B
Net Income (TTM)
$108.12B
EPS (TTM)
$1.82
P/E Ratio
5.57
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$10.15
Volume
7
Open
$10.15
Price
$10.15
Volume
7
Open
$10.15
Previous Close
$10.15
Daily Range
$10.15 - $10.15
52-Week Range
$6.34 - $19.20
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$10.15
Volume
7
Open
$10.15
Previous Close
$10.15
Daily Range
$10.15 - $10.15
52-Week Range
$6.34 - $19.20
DNPUF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sumitomo Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
3,832
CEO
Toru Kimura, PhD
Website
www.sumitomo-pharma.co.jpHeadquarters
Osaka, 541-0045, JP
DNPUF Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
11%
Net Income Margin
24%
Return on Equity
49%
Return on Capital
9%
Return on Assets
13%
Earnings Yield
17.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.55B
Shares Outstanding
448.59M
Volume
7
Avg. Volume
520.734
Financials (TTM)
Gross Profit
$258.51B
Operating Income
$50.66B
EBITDA
$71.57B
Operating Cash Flow
$72.17B
Capital Expenditure
$4.64B
Free Cash Flow
$67.53B
Cash & ST Invst.
$44.59B
Total Debt
$218.55B
Sumitomo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$106.21B
+0.5%
Gross Profit
$54.63B
-17.2%
Gross Margin
51.43%
N/A
Market Cap
$4.55B
N/A
Market Cap/Employee
$914.30K
N/A
Employees
4,980
N/A
Net Income
$817.11M
-133.8%
EBITDA
$89.56M
-98.4%
Quarterly Fundamentals
Net Cash
$173.96B
+34.5%
Accounts Receivable
$135.53B
+81.1%
Inventory
$85.95B
-8.8%
Long Term Debt
$180.18B
-30.4%
Short Term Debt
$38.37B
-17.4%
Return on Assets
13.28%
N/A
Return on Invested Capital
9.44%
N/A
Free Cash Flow
$28.83B
+233.9%
Operating Cash Flow
$29.63B
+169.2%